Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2020 Filed May 15, 2020 23:35 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 51,488 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-20-029868 · doc4.xml · derivative · entry 14 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,134,384 Underlying: Common Stock · 51,488 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 13, 2020 Filed May 15, 2020 23:35 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,901 | $26.89 | $51,117.89 |
DisclosureSEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,010 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.72 to $27.27 inclusive. Read SEC document |
| May 13, 2020 Filed May 15, 2020 23:35 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 9,378 | $26.05 | $244,296.90 |
DisclosureSEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,911 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.68 to $26.66 inclusive. Read SEC document |
| May 13, 2020 Filed May 15, 2020 23:35 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 27,684 | $25.12 | $695,422.08 |
DisclosureSEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,289 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.68 to $25.67 inclusive. Read SEC document |
| May 13, 2020 Filed May 15, 2020 23:35 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 12,525 | $24.24 | $303,606.00 |
DisclosureSEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,973 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.68 to $24.62 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9) and (10). Read SEC document |
| May 13, 2020 Filed May 15, 2020 23:35 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 51,488 | $0.91 | $46,854.08 |
DisclosureSEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:50 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,512 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-20-005845 · edgar.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,185,872 Underlying: Common Stock · 8,512 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:50 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,512 | $22.17 | $188,711.04 |
DisclosureSEC source: 0001179110-20-005845 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,010 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.14 to $22.24 inclusive. Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:50 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 8,512 | $0.91 | $7,745.92 |
DisclosureSEC source: 0001179110-20-005845 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2020 Filed May 13, 2020 01:50 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-20-005845 · edgar.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,194,384 Underlying: Common Stock · 20,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 08, 2020 Filed May 13, 2020 01:50 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 200 | $23.24 | $4,648.00 |
DisclosureSEC source: 0001179110-20-005845 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,010 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020. Read SEC document |
| May 08, 2020 Filed May 13, 2020 01:50 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 19,800 | $22.72 | $449,856.00 |
DisclosureSEC source: 0001179110-20-005845 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,210 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.18 to $23.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3. Read SEC document |
| May 08, 2020 Filed May 13, 2020 01:50 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 20,000 | $0.91 | $18,200.00 |
DisclosureSEC source: 0001179110-20-005845 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2019 Filed Oct 30, 2019 01:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 960,007 | $12.22 | $11,731,285.54 |
DisclosureSEC source: 0001209191-19-054409 · doc4.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,010 F1 · price: These shares were sold by the Reporting Person as a selling stockholder pursuant to an underwritten public offering by the Issuer. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 10:07 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 660,007 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-19-054033 · doc4.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,214,384 Underlying: Common Stock · 660,007 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 10:07 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 660,007 | $0.91 | $600,606.37 |
DisclosureSEC source: 0001209191-19-054033 · doc4.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,540,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.